Sam Emaminejad, assistant professor of electrical engineering at UCLA, has demonstrated that a wearable biosensor can be used in the diagnosis of cystic fibrosis, diabetes and other diseases.
UCLA biochemists have devised a way to convert sugar into a variety of useful chemical compounds without using cells and that could lead to the production of biofuels and pharmaceuticals.
The new technique can accurately identify a person’s optimal drug and dose combinations throughout an entire course of treatment, without complex, time-consuming genetic analysis.
Thyrosim can be used by clinicians, researchers and educators to gauge the impacts of thyroid treatments and to develop more effective remedies for thyroid problems.
A new event created by the Ozcan Research Group of UCLA’s Henry Samueli School of Engineering and Applied Science showcased an impressive array of biomedical engineering technology research.